The 20 Best Squamous Cell Skin Carcinoma Doctors Near Me in Rosedale, MD

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Squamous Cell Skin Carcinoma, and Pancreaticoduodenectomy.

Maie John is an Otolaryngologist in Baltimore, Maryland. Dr. John is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Melanoma, Glossectomy, and Gastrostomy.

Dr. Howard Hines is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatology, melanoma and psoriasis. He received his B.A. in biology from Western Maryland College and his M.D. from the University of Maryland School of Medicine. He completed his residency in general internal medicine at Washington Hospital Center and performed a fellowship in dermatology at George Washington University Hospital. Dr. Hines is a member of several professional organizations, including the American Medical Association, American College of Physicians and American Society of Internal Medicine. CV http://www.hopkinsmedicine.org/dermatology/our_experts/_documents/Howard_C_Hines_Curriculum_vitae.doc Selected Publications Boudreau S, Hines HC, Hood AF. “Dermal abscess with staphylococcus aureus, cytomegalovirus, and acid-fast bacilli in a patient with acquired immunodeficiency syndrome.” Journal of Cutaneous Pathology. 1988;15:53-57. Horn TD, Hines HC. “Erythrophagocytosis in the skin: case report.” Journal of Cutaneous Pathology. 1988;15:399-403. Jawitz JC, Hines HC. “Treatment of eczema herpeticum with systemic acyclovir.” Archives of Dermatology. February 1985;121:274-275. Dr. Hines is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His top areas of expertise are Pigmented Purpuric Dermatosis, Actinic Keratosis, Universal Acquired Melanosis, and Liver Spots.

Dr. Sewon Kang is the Noxell Professor and Chairman of the Department of Dermatology at the Johns Hopkins University School of Medicine and the Dermatologist-in-Chief of Johns Hopkins Hospital. He is also founder and co-Director of the Cutaneous Translational Research Program (CTReP) at Hopkins. A recipient of the Dermatology Foundation's Career Development Award, he has received other research awards and grants from the American Dermatological Association, the National Psoriasis Foundation and the National Institutes of Health (Roadmap T32, K24, and R01). His research focus has been in the areas of skin pharmacology and photomedicine. He is the Past President of the Photomedicine Society, and the American Acne and Rosacea Society. Dr. Kang is or has been on the Board of Directors of multiple organizations including, the Society for Investigative Dermatology, the Association of Professors of Dermatology, the Dermatology Foundation, and the Skin of Color Society. An author on over 240 publications and book chapters, Dr. Kang is also the Editor-in-Chief of the 9th edition of the Fitzpatrick's Dermatology textbook. He is an inventor/co-inventor of 17 patents and has given over 300 presentations globally. A graduate with honors from Williams College and the University of Michigan, Dr. Kang completed dermatology residency and fellowship at the Harvard Medical School/Massachusetts General Hospital. He sees patients exclusively at the Johns Hopkins Hospital, and his areas of clinical expertise include photomedicine, skin cancer (melanoma), skin aging, and dermatology for ethnic skin. Dr. Kang is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His top areas of expertise are Melanoma, Acne, Prurigo Nodularis, and Rosacea.

Dr. Jaroslaw Jedrych is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatopathology and anatomic pathology. Dr. Jedrych received his M.D. from the Warsaw Medical University. He completed his residency in anatomic pathology at Yale School of Medicine, where he served as chief resident. He then completed his fellowship in oncologic pathology at Memorial Sloan Kettering Cancer Center, where he served as chief fellow, and a dermatopathology fellowship at University of Pittsburgh Medical Center. Dr. Jedrych is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His top areas of expertise are Epidermodysplasia Verruciformis, Trichoepithelioma, Warts, and Grover's Disease.

Fyza Shaikh is an Assistant Professor in Cancer Immunology in the Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center. She joined the faculty after completing her fellowship in medical oncology at Johns Hopkins School of Medicine (JHSOM) and residency in internal medicine at the University of Pittsburgh Medical Center as part of the ABIM research pathway. She received her MD and PhD in Microbiology and Immunology at Vanderbilt University School of Medicine. The Shaikh lab at JHSOM is focused on how the microbiome impacts host immunological responses to tumorigenesis and anti-tumor responses to immunomodulatory agents. The lab uses a combination of translational approaches using samples collected from human cohort studies and clinical trials as well as murine models to ask more detailed mechanistic questions and works across multiple tumor types (melanoma, lung, esophageal, head and neck, etc). The overall approach uses combination of clinical, computational, and lab-based techniques using a rich biorepository containing clinically annotated metadata with known and putative biomarkers of ICI response, such as PD-L1 and tumor mutational burden, paired with longitudinal fecal and plasma samples that correlate with clinical milestones (i.e. response/nonresponse by imaging and treatment-related toxicity). The goal is to focus on microbial functionality and build defined bacterial consortia that can then be tested in murine models to define colonization, metabolomics, and intra-tumoral immune response. This translational approach, with cross-sectional and longitudinal analysis of human samples, paired with mechanistic studies in murine models, has the potential to address both limitations in previously published studies and generate new hypotheses to make advances in this field and improve ICI responses for patients with advanced malignancies. Dr. Shaikh is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Melanoma, and Esophageal Cancer.

Shawn Kwatra is a Dermatologist in Baltimore, Maryland. Dr. Kwatra is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His top areas of expertise are Prurigo Nodularis, Atopic Dermatitis, Lichen Simplex Chronicus, and Psoriasis.

Manisha Loss is a Dermatologist in Baltimore, Maryland. Dr. Loss is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. Her top areas of expertise are Melanoma, Multiple Familial Trichoepithelioma, Trichoepithelioma, and Giant Congenital Nevus.

Thomas Smith is a Dermatologist in Rosedale, Maryland. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His top areas of expertise are Nummular Eczema, Actinic Keratosis, Warts, and Seborrheic Keratosis.

James Poulton is a Dermatologist in Rosedale, Maryland. Dr. Poulton is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His top areas of expertise are Nummular Eczema, Actinic Keratosis, Warts, and Seborrheic Keratosis.

Stephen Ronson is a Radiation Oncologist in Rosedale, Maryland. Dr. Ronson is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Primitive Neuroectodermal Tumor (PNET), and Posterior Fossa Tumor.

Kelly Orwat is a Radiologist in Rosedale, Maryland. Dr. Orwat is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. Her top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Metastatic Brain Tumor, and Posterior Fossa Tumor.

Oanh Lauring is a Dermatologist in Nottingham, Maryland. Dr. Lauring is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. Her top areas of expertise are Actinic Keratosis, Warts, Intertrigo, and Rosacea.

Daren Simkin is a Dermatologist in Baltimore, Maryland. Dr. Simkin is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His top areas of expertise are Actinic Keratosis, Warts, Liver Spots, and Universal Acquired Melanosis.

Regina Anderson is an Internal Medicine provider in Baltimore, Maryland. Dr. Anderson is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. Her top areas of expertise are Actinic Keratosis, Warts, Basal Cell Skin Cancer, and Squamous Cell Skin Carcinoma.

Andrew Day is a Plastic Surgeon and an Otolaryngologist in Baltimore, Maryland. Dr. Day is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His top areas of expertise are Tongue Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Tissue Biopsy, and Gastrostomy.

Paul Manson is a Plastic Surgeon in Baltimore, Maryland. Dr. Manson is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, Craniectomy, and Tissue Biopsy.

Dr. Tanguy Seiwert is an oncologist in Baltimore, caring for patients with head and neck cancer. He serves as the director of the Head and Neck Cancer Oncology Disease Program and the co-director of the Bloomberg~Kimmel Institute for Immunotherapy at the Head and Neck Cancer Program at the Johns Hopkins School of Medicine. Dr. Seiwert earned his M.D. at Johannes Gutenberg Universität in Mainz, Germany. He completed his residency at the Duke University School of Medicine and performed a fellowship in hematology/oncology at the University of Chicago Medicine Mitchell Hospital-Hyde Park. Dr. Seiwert joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Seiwert was director of the Head and Neck Cancer Program at the University of Chicago. Dr. Seiwert’s research interests include immunologic and genomic profiling. He has given numerous invited talks on head and neck cancer both nationally and internationally. Dr. Seiwert served as chief editor for Frontiers in Head and Neck Cancer and as an editorial board member for the Journal of Clinical Oncology and Oral Oncology. He is a reviewer for multiple medical journals, including Lancet Oncology, Annals of Oncology and Clinical Cancer Research. He has been recognized by the American Association for Clinical Oncology for multiple Merit Awards and a Young Investigator Award. He was a member of the NCI Head and Neck Cancer Steering Committee, and is a member of the American Association for Clinical Oncology, the Society for Immunotherapy of Cancer, and the European Society of Clinical Oncology. Dr. Seiwert is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His top areas of expertise are Glioma, Laryngeal Cancer, Tongue Cancer, Oral Squamous Cell Carcinoma, and Gastrostomy.

Jennifer Powers is a Plastic Surgeon and a Dermatologist in Baltimore, Maryland. Dr. Powers is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. Her top areas of expertise are Basal Cell Skin Cancer, Actinic Keratosis, Pityriasis Rubra Pilaris, and Squamous Cell Skin Carcinoma.

Dr. Harry Quon is an associate professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also holds appointments in oncology and in otolaryngology - head and neck surgery. His area of clinical expertise is radiation treatment for head and neck cancers. He serves as the co-director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic. Dr. Quon received his M.D. from the University of Toronto Institute of Medical Science. He completed his residency at the Princess Margaret Hospital in Ontario and performed a fellowship in radiation oncology at the Princess Margaret Hospital and the Beth Israel Medical Center. Make A Gift. Dr. Quon is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Dry Mouth, Gastrostomy, and Prostatectomy.